CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL]

Suppliers

Names

[ CAS No. ]:
80663-95-2

[ Name ]:
CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL]

[Synonym ]:
meta-iodobenzylguanidine
3-iodo benzyl guanidine
m-Iod-6-benzylaminopurin
N-Dimethylhomotryptamin
N-Dimethylhomotryptamine
MFCD00151189

Chemical & Physical Properties

[ Density]:
1.85g/cm3

[ Boiling Point ]:
382.1ºC at 760mmHg

[ Molecular Formula ]:
C16H22I2N6O4S

[ Molecular Weight ]:
648.25800

[ Flash Point ]:
184.9ºC

[ Exact Mass ]:
647.95100

[ PSA ]:
206.78000

[ LogP ]:
5.35840

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
29252900

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 1-(3-Iodophenyl)methanamine
  • METHYL THIOPSEUDOUREA SULFATE
  • m-iodobenzylguanidine dihydrogen carbonate
  • Cyanamide
  • Benzylamine, m-iodo-, hydrochloride
  • N,N,N-Tributyl-1-butanaminium thiocyanate

DownStream

Articles

Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65.

Sci. Signal. 7(351) , ra106, (2014)

Inflammation increases the abundance of inducible nitric oxide synthase (iNOS), leading to enhanced production of nitric oxide (NO), which can modify proteins by S-nitrosylation. Enhanced NO productio...

The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.

Int. J. Mol. Med. 34(3) , 842-8, (2014)

The aim of the present study was to investigate the effects of meta-iodobenzylguanidine (MIBG) on the invasive properties of hepatocellular carcinoma (HCC) cells and examine whether these effects are ...

Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.

Mol. Imaging Biol. 17(2) , 284-94, (2015)

Iodine-131-m-iodobenzylguanidine ([(131)I]mIBG)-targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30-40 %. The aim of this st...


More Articles

Related Compounds

  • N-[(3-iodophenyl)methyl]ethanamine,hydrochloride
  • N-[(3-iodophenyl)methyl]propan-1-amine
  • 4-[(3-iodophenyl)methyl]morpholine
  • 9-[(3-iodophenyl)methyl]-N,N-dimethylpurin-6-amine
  • 2-[(3-iodophenyl)methyl]-2-naphthalen-1-ylindene-1,3-dione
  • 2-[(3-iodophenyl)methyl]-1,2-thiazol-3-one
  • 3-Methyl-1-phenyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 3-(4-Bromopyridin-3-yl)thiazolidine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • [5-(methoxymethyl)-1-(3-methylbutyl)-1H-1,2,3-triazol-4-yl]methanol
  • 2-(3-methyl-1H-pyrazol-5-yl)piperidine
  • 7-chloro-2-ethyl-3,4-dihydro-2H-1,4-benzoxazine
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol